Response to 'COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations': reply from the authors.

Afra, T P; Siraj, M M; Razmi T, M

Afra, T P; Siraj, M M; Razmi T, M.

Afra TP; Department of Dermatology, IQRAA Aesthetics, IQRAA International Hospital and Research Centre, Calicut, Kerala, India.
Siraj MM; Department of Critical Care, Harrison Miller Healthcare, Calicut, Kerala, India.
Razmi T M; Department of Dermatology, IQRAA Aesthetics, IQRAA International Hospital and Research Centre, Calicut, Kerala, India.

Br J Dermatol ; 185(4): 872-873, 2021 10.

Article in English | MEDLINE | ID: covidwho-1307672

Subject(s)

COVID-19; Mucocutaneous Lymph Node Syndrome; Adult; Humans; Mucocutaneous Lymph Node Syndrome/complications; Mucocutaneous Lymph Node Syndrome/drug therapy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Mucocutaneous Lymph Node Syndrome Topics: Long Covid Limits: Adult / Humans Language: English Journal: Br J Dermatol Year: 2021 Document Type: Article Affiliation country: Bjd.20638

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google